ArchiMed related stories
All articles and analysis
Industry consolidation will lead to more spin-outs to back – UnigestionThe hunger and entrepreneurship of private equity professionals shouldn't be underestimated, global head of primary fund investments Kim Pochon tells PEI.
Why spin-outs could be the future of first-time fundsThere are multiple reasons why spin-out teams are uniquely positioned to overcome hurdles facing first-time fund managers, writes Karl Adam, a partner at placement agent and advisory firm Monument Group.
Side Letter: Delaying your next raiseA fundraising expert is urging GPs to avoid the temptation to launch their next vintage too early. Plus: Hamilton Lane's evergreen capital is soaring; and why impact investing is being hindered Down Under. Here's today's brief, for our valued subscribers only.
Three key trends in healthcareFundraising for healthcare vehicles increased markedly in 2023 as PE firms continued to back businesses across a range of verticals.
ArchiMed launches small-cap product to fill void left by flagshipsThe firm has set a €400m hard-cap for ArchiMed MED Rise, according to documents prepared by a US pension.
PEI Awards 2023: EMEA winnersCVC Capital partners scoops five awards, including, for the first time, lender of the year.
What to expect from APAC private equity in 2024GP stakes, healthcare and Middle Eastern investors will be front of mind for Asia-Pacific markets in 2024.
Continuation funds continue their streak: Story of the YearIn 2023, continuation funds spread to geographic markets anew and niche strategies such as impact funds, while increasingly involving complex situations and assets.
From hype to reality: continuation funds bear fruit for LPsA recent continuation fund exit by TPG is further evidence that such vehicles can reward investors with the capacity and desire to roll over, or those who opt to back funds investing in these deals.
Side Letter: LPs desire debtThursday is Thanksgiving for our readers in the US, so we'll return to your inboxes on Monday. In the meantime, private debt's rising appeal may come at the expense of private equity allocations. Plus: why UK dealmaking could be set to explode. Here's today's brief, for our valued subscribers only.